Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T86591 | Target Info | |||
Target Name | Peroxisome proliferator-activated receptor alpha (PPARA) | ||||
Synonyms | Peroxisome proliferater-activated receptor alpha; PPARalpha; PPAR-alpha; PPAR; Nuclear receptor subfamily 1 group C member 1; NR1C1 | ||||
Target Type | Successful Target | ||||
Gene Name | PPARA | ||||
Biochemical Class | Nuclear hormone receptor | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Icosapent | Ligand Info | |||
Canonical SMILES | CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O | ||||
InChI | 1S/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15- | ||||
InChIKey | JAZBEHYOTPTENJ-JLNKQSITSA-N | ||||
PubChem Compound ID | 446284 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6LXA X-ray structure of human PPARalpha ligand binding domain-eicosapentaenoic acid (EPA) co-crystals obtained by delipidation and cross-seeding | ||||||
Method | X-ray diffraction | Resolution | 1.23 Å | Mutation | No | [1] |
PDB Sequence |
MTADLKSLAK
208 RIYEAYLKNF218 NMNKVKARVI228 LSGKSNNPPF239 VIHDMETLCM249 AEKTLVAKLV 259 ANGIQNKEAE269 VRIFHCCQCT279 SVETVTELTE289 FAKAIPGFAN299 LDLNDQVTLL 309 KYGVYEAIFA319 MLSSVMNKDG329 MLVAYGNGFI339 TREFLKSLRK349 PFCDIMEPKF 359 DFAMKFNALE369 LDDSDISLFV379 AAIICCGDRP389 GLLNVGHIEK399 MQEGIVHVLR 409 LHLQSNHPDD419 IFLFPKLLQK429 MADLRQLVTE439 HAQLVQIIKK449 TESDAALHPL 459 LQEIYRDMY
|
|||||
|
ILE241
3.245
LEU247
3.678
ALA250
3.165
GLU251
2.919
LEU254
3.528
VAL255
3.359
ARG271
4.586
ILE272
2.730
PHE273
2.914
CYS275
3.365
CYS276
2.942
GLN277
3.081
THR279
2.613
SER280
2.693
TYR314
2.629
ILE317
4.902
|
|||||
PDB ID: 7BQ4 X-ray structure of human PPARalpha ligand binding domain-eicosapentaenoic acid (EPA)-SRC1 coactivator peptide co-crystals obtained by delipidation and co-crystallization | ||||||
Method | X-ray diffraction | Resolution | 1.62 Å | Mutation | No | [1] |
PDB Sequence |
ADLKSLAKRI
210 YEAYLKNFNM220 NKVKARVILS230 GPPFVIHDME245 TLCMAEKTLV255 AKLVANNKEA 268 EVRIFHCCQC278 TSVETVTELT288 EFAKAIPGFA298 NLDLNDQVTL308 LKYGVYEAIF 318 AMLSSVMNKD328 GMLVAYGNGF338 ITREFLKSLR348 KPFCDIMEPK358 FDFAMKFNAL 368 ELDDSDISLF378 VAAIICCGDR388 PGLLNVGHIE398 KMQEGIVHVL408 RLHLQSNHPD 418 DIFLFPKLLQ428 KMADLRQLVT438 EHAQLVQIIK448 KTESDAALHP458 LLQEIYRDMY 468
|
|||||
|
ILE241
3.366
LEU247
3.850
ALA250
3.056
GLU251
3.044
LEU254
3.486
VAL255
3.579
ARG271
4.879
ILE272
2.712
PHE273
3.356
CYS275
3.626
CYS276
2.838
GLN277
3.423
THR279
2.653
SER280
2.737
TYR314
2.555
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | PPARAlpha Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates. iScience. 2020 Oct 23;23(11):101727. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.